Controlled Trial of Gastric Electrical Stimulation in Children
Part of paid clinical trials in Columbus, Ohio.
- Sponsor
- Nationwide Children's Hospital
- Study ID
- NCT07474415
- Status
- Completed
Conditions
- Functional Dyspepsia
- Gastroparesis
- Vomiting Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - 21 Years
- Healthy Volunteers
- Not accepted
Interventions
- Temporary Gastric Electrical Stimulation — DEVICEParticipants underwent placement of a temporary gastric pacing lead through a nasogastric tube connected to an external gastric electrical stimulator. The device was used to deliver gastric electrical stimulation during the active phase of the study. During the sham phase the device remained OFF, while during the active phase electrical stimulation was delivered to the stomach. The intervention was used to evaluate the effects of gastric electrical stimulation on symptoms of nausea and vomiting and tolerance to oral nutrient intake in children with refractory symptoms.
Study Details
This study evaluates whether gastric electrical stimulation (GES) improves symptoms in children with severe nausea and vomiting that have not responded to standard treatments. GES is a therapy that delivers small electrical pulses to the stomach to help improve stomach function and reduce symptoms. In this study, children underwent temporary gastric electrical stimulation using a pacing lead placed through a nasogastric tube. The stimulation device was turned OFF for four days and then ON for four days, while participants remained blinded to the stimulation status. Symptoms and tolerance to oral nutrient intake were measured at baseline and during each study phase. The goal of the study was to determine whether active stimulation improves symptoms and nutrient intake compared with the sham period.
Key Dates
- Start date
- Nov 25, 2019
- Status verified
- Mar 2026
- Primary completion
- Oct 21, 2024
- Completion
- Oct 21, 2025
Study Design
- Enrollment
- 30 participants (actual)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Temporary Gastric Electrical Stimulation (Sham and Active Phases)Participants undergo placement of a temporary gastric pacing lead connected to an external stimulator. The stimulator remains OFF for the first four days (sham phase) and is then turned ON for the following four days (active stimulation phase). Participants are blinded to stimulation status.
Primary Outcome Measure
Change in Symptom Monitor Worksheet (SMW) Score [ Time Frame: Baseline, Day 5 (end of sham phase), and Day 9 (end of active stimulation phase) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Nationwide Children's Hospital | Columbus | Ohio | 43205 | - |
Find similar trials in Columbus, OH
Related Studies
- Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in DiabetesRecruiting · Matthew Allemang · Cleveland, Ohio
- BSGM to Evaluate Patients With GI SymptomsRecruiting · Children's Hospital of Philadelphia · San Diego, California
- GpCRC Pediatric Gastroparesis Registry 2Recruiting · Johns Hopkins Bloomberg School of Public Health · Boston, Massachusetts
- Domperidone in Treating Patients With Gastrointestinal DisordersPHASE3 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas